dapagliflozin NDC 67296-2334

NDC codes

FDA NDC Directory

Product NDC (as listed)67296-2334Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67296-2334Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
67296-2334-3	67296233403	30 TABLET in 1 BOTTLE (67296-2334-3)Marketed from Apr 6, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): dapagliflozin
Generic name (nonproprietary): dapagliflozin
Active ingredients: Dapagliflozin — 10 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Redpharm Drug
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211506
Marketing start: Apr 6, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Sodium-Glucose Transporter 2 Inhibitors (Mechanism)
Identifiers: Product ID 67296-2334_5b436f3c-1ff7-de87-e063-6294a90a5561SPL ID 5b436f3c-1ff7-de87-e063-6294a90a5561
Pharmacologic class: Sodium-Glucose Cotransporter 2 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N467296233403 followed by a unit qualifier and the quantity

Package 67296-2334-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 211506

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211506
Product	Strength	Form · route	Labeler	Product NDC
dapagliflozin	Dapagliflozin 5 mg/1	TabletOral	Macleods Pharmaceuticals Limited	33342-585
dapagliflozin	Dapagliflozin 10 mg/1	TabletOral	Macleods Pharmaceuticals Limited	33342-586